Today, there is no routinely and validated diagnostic methods to measure insulin sensitivity and, above all, there is no practical need to such a measurement, neither to predict type 2 diabetes nor to monitor the glycemic and metabolic control once the disease ensues. This evidence concerns the gene INS and type 2 diabetes mellitus.